Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleSystemic Lupus Erythematosus
Open Access

Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis

Konstantinos Tselios, Dafna D. Gladman, Cameron Taheri, Jiandong Su and Murray B. Urowitz
The Journal of Rheumatology February 2021, 48 (2) 228-231; DOI: https://doi.org/10.3899/jrheum.200161
Konstantinos Tselios
1K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Konstantinos Tselios
Dafna D. Gladman
1K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dafna D. Gladman
Cameron Taheri
1K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiandong Su
1K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray B. Urowitz
1K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Murray B. Urowitz
  • For correspondence: m.urowitz{at}utoronto.ca
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 48 no. 2 228-231
DOI 
https://doi.org/10.3899/jrheum.200161
PubMed 
33259331

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication August 14, 2020
  • Published online February 1, 2021.

Article Versions

  • Latest version (September 1, 2020 - 04:00).
  • Latest version (December 15, 2020 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2021 by the Journal of Rheumatology Free online via JRheum Full Release option

Author Information

  1. Konstantinos Tselios1,
  2. Dafna D. Gladman1,
  3. Cameron Taheri1,
  4. Jiandong Su1 and
  5. Murray B. Urowitz1⇑
  1. 1K. Tselios, MD, PhD, D.D. Gladman, MD, FRCPC, C. Taheri, BHSc, J. Su, MB, MSc, M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre of Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto, Ontario, Canada.
  1. Address correspondence to Dr. M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, ON M5T 2S8, Canada. Email: m.urowitz{at}utoronto.ca.

Article usage

Article usage: August 2020 to June 2026

AbstractFullPdf
Aug 2020903
Sep 2020225072
Oct 202054019
Nov 20204109
Dec 20204490120
Jan 20213614141
Feb 2021427954123
Mar 202114453462
Apr 20217047659
May 202110444234
Jun 2021486726
Jul 2021255744
Aug 2021353635
Sep 2021386549
Oct 2021375667
Nov 20212013753
Dec 20211915753
Jan 2022255139
Feb 2022143920
Mar 20224211839
Apr 20221711238
May 2022115737
Jun 2022115529
Jul 202275228
Aug 2022136034
Sep 2022116430
Oct 2022153725
Nov 202276723
Dec 202235916
Jan 20231513132
Feb 2023107521
Mar 202386923
Apr 202397027
May 202377229
Jun 2023116335
Jul 202346237
Aug 202394837
Sep 202354431
Oct 2023785334
Nov 2023974624
Dec 202384723
Jan 2024226045
Feb 2024156535
Mar 2024865929
Apr 202475940
May 202458633
Jun 202444832
Jul 2024136133
Aug 2024145521
Sep 202495431
Oct 202467239
Nov 202487033
Dec 202448543
Jan 202597734
Feb 20251911262
Mar 2025413453
Apr 202514119109
May 20251724350
Jun 202513327445
Jul 20253823942
Aug 20253134757
Sep 20251629438
Oct 20252324155
Nov 20254433837
Dec 20253330952
Jan 20265342835
Feb 20265243852
Mar 20265637877
Apr 20265828077
May 20262821732
Jun 202662247029

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 48, Issue 2
1 Feb 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
Konstantinos Tselios, Dafna D. Gladman, Cameron Taheri, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Feb 2021, 48 (2) 228-231; DOI: 10.3899/jrheum.200161

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
Konstantinos Tselios, Dafna D. Gladman, Cameron Taheri, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Feb 2021, 48 (2) 228-231; DOI: 10.3899/jrheum.200161
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

endstage kidney disease
LUPUS NEPHRITIS
rapid progression

Related Articles

Cited By...

More in this TOC Section

  • Differences in Self-Reported Medication Nonadherence and Its Drivers in Young Adults Versus Older Adults With Systemic Lupus Erythematosus
  • Perceived and Objective Physical Function in 2 United States Population-Based Cohorts of Adults With Systemic Lupus Erythematosus
  • Performance of Risk Score Calculators in the Identification of Coronary Artery Calcification in Patients With Systemic Lupus Erythematosus
Show more Systemic Lupus Erythematosus

Similar Articles

Keywords

  • endstage kidney disease
  • lupus nephritis
  • rapid progression

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire